Monitor blood glucose more frequently during the introduction phase (weeks 1-4) and adjust diabetes medications under your provider supervision to avoid hypoglycemia
In rare cases, some people may experience mild nausea, fatigue, or irritation at the injection site
64 , e01888-19 (2020)
Yet, while their ability to reduce body weight and insulin levels was greater than GLP1 monotherapy in male models 33,34,35 , the potential of these GLP1-based multi-agonists for the treatment of the metabolic, hormonal, and gonadal complications associated with PCOS has not been explored to date
Rachel Goldman , PhD, FTOS, FASMBS-IH, Licensed Psychologist and Clinical Assistant Professor at NYU Grossman School of Medicine